Christine Connolly, MD
Ophthalmology · New Orleans, LANPI 1144410606
Payments from drug & device makers
Across 45 payments — averaging $55.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Alcon$306
- Novartis$56
- Tarsus Pharmaceuticals, Inc.$54
- Bausch & Lomb, A Division Of Bausch Health US, LLC$40
- Averitas Pharma Inc.$39
- plus $111 from 4 others
What the payments were for
- Travel & lodging$1,31453%
- Food & beverage$1,18147%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 16 | $1,888 |
| Alcon | 15 | $306 |
| Novartis | 3 | $56 |
| Tarsus Pharmaceuticals, Inc. | 2 | $54 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $40 |
| Averitas Pharma Inc. | 2 | $39 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Merz Pharmaceuticals, LLC | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $28 |
| Harrow Eye, LLC | 1 | $25 |
How this compares
$2,494 in reported general payments places this provider in the 55th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 17 | $10,242 |
| Cyclosporine | 14 | $4,251 |
| Prednisolone Acetate | 49 | $2,007 |
| Latanoprost | 251 | $1,813 |
| Ketorolac Tromethamine | 57 | $1,444 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 47 | $526 |
| Dorzolamide Hcl | 26 | $419 |
| Brimonidine Tartrate | 51 | $398 |
| ErythromycinErythromycin Base | 21 | $232 |
| Timolol Maleate | 34 | $217 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in New Orleans
- Delmar CaldwellNew Orleans$282K
- Ze ZhangNew Orleans$103K
- Rebecca MetzingerNew Orleans$63K
- Peter KastlNew Orleans$32K
- Benjamin LeeNew Orleans$7K
- Glen CangelosiNew Orleans$6K
- Matthew BoltonNew Orleans$5K
- Blake WilliamsonBaton Rouge$482K
- William ReadMonroe$303K
- Ruben GrigorianWest Monroe$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.